Literature DB >> 1876228

Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys.

J J Buccafusco1, W J Jackson.   

Abstract

Our earlier studies have demonstrated that administration of low micrograms/kg doses of nicotine to young adult monkeys prior to a delayed matching-to-sample (DMTS) task resulted in a centrally mediated improvement in performance of the task, particularly when delay intervals which most greatly challenged the animal's capabilities were involved. The present study confirmed these findings using a completely computer driven and automated procedure. In addition, performance on the DMTS was observed to be enhanced when animals were again tested 24 h after the dose of nicotine. Further analysis of the data indicated that the majority of enhancement to nicotine could be accounted for by a greatly increased performance at the least preferred stimulus color. Position preference (left vs. right stimulus) was not a factor in nicotine-induced enhancement. Two aged monkeys (34 years old Macaca mulatta) were significantly more difficult to train in the DMTS task and their longest delay capabilities were significantly shorter than the young animals (Macaca fascicularis). Nevertheless, the aged animals were essentially similar in most respects in their responses to nicotine administration. These data are consistent with a role for central nicotinic systems in memory performance and with the ability of nicotine to produce enhancement of selective features of mnemonic strategy in young and old monkeys. Furthermore, it is possible that either model, the aged animal, or the young animal stressed to his mnemonic capability may provide a good model for learning and memory disorders in humans.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1876228     DOI: 10.1016/0197-4580(91)90102-p

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  39 in total

1.  A computer-assisted cognitive test battery for aged monkeys.

Authors:  Jerry J Buccafusco; Alvin V Terry; Paul B Murdoch
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

2.  Effects of acute and chronic cocaine administration on titrating-delay matching-to-sample performance.

Authors:  Brian D Kangas; Marc N Branch
Journal:  J Exp Anal Behav       Date:  2012-03       Impact factor: 2.468

Review 3.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

Review 4.  Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits.

Authors:  Manoranjan S D'Souza; Athina Markou
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

Review 5.  Multifunctional receptor-directed drugs for disorders of the central nervous system.

Authors:  Jerry J Buccafusco
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

6.  Pharmacological characterization of nicotine-induced acetylcholine release in the rat hippocampus in vivo: evidence for a permissive dopamine synapse.

Authors:  R T Reid; G K Lloyd; T S Rao
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 7.  Neurobiology of nAChRs and cognition: a mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career.

Authors:  Alvin V Terry; Michael W Decker
Journal:  Biochem Pharmacol       Date:  2011-06-12       Impact factor: 5.858

8.  Nicotinic receptor-mediated reduction in L-DOPA-induced dyskinesias may occur via desensitization.

Authors:  Tanuja Bordia; Carla Campos; J Michael McIntosh; Maryka Quik
Journal:  J Pharmacol Exp Ther       Date:  2010-03-03       Impact factor: 4.030

9.  A critical examination of best dose analysis for determining cognitive-enhancing potential of drugs: studies with rhesus monkeys and computer simulations.

Authors:  Paul L Soto; Jesse Dallery; Nancy A Ator; Brian R Katz
Journal:  Psychopharmacology (Berl)       Date:  2013-03-26       Impact factor: 4.530

10.  Nicotinic systems and cognitive function.

Authors:  E D Levin
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.